ZP
MIST icon

Zimmer Partners’s Milestone Pharmaceuticals MIST Stock Holding History

Zimmer Partners’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-160,000
Closed -$2.56M – 91
2019
Q4 		$2.56M Hold
160,000
– – 0.04% 67
2019
Q3 		$2.98M Hold
160,000
– – 0.03% 86
2019
Q2 		$4.34M Buy
+160,000
New +$3.3M 0.05% 83

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zimmer Partners's MIST Position: Q1 2020 in Review

Zimmer Partners sold out of Milestone Pharmaceuticals (MIST) in Q1 2020, closing a stake of 160,000 shares — an estimated $2.56M sold.

Zimmer Partners first reported a position in MIST in Q2 2019 and held it in 3 quarters. The position peaked at $4.34M in Q2 2019. 19 funds tracked by Wall St. Rank hold MIST as of Q1 2020.

  • Zimmer Partners reported no remaining Milestone Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Zimmer Partners sold 160,000 Milestone Pharmaceuticals shares in Q1 2020, an estimated $2.56M.
  • Zimmer Partners first reported a position in Milestone Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • Zimmer Partners's Milestone Pharmaceuticals position peaked at $4.34M in Q2 2019.
  • 19 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2020.

Based on Zimmer Partners's 13F filing for Q1 2020, filed 15 May 2020.